After decades of fits and starts, scientists finally got the world’s first vaccines against respiratory syncytial virus ...

Acute respiratory syncytial virus was associated with elevated incidence of cardiovascular events among older adults, ...

Older adults and people with certain medical conditions are more likely to receive the respiratory syncytial virus (RSV) ...

Adults diagnosed with RSV-associated acute respiratory infection face nearly triple the risk of death within 1 year compared ...

A major study presented today at ESCMID Global 2025 has revealed that adults with respiratory syncytial virus-associated ...

In a new cross-sectional analysis of 6,746 hospitalized adults aged 60 and older in 20 states, increased respiratory ...

Knowledge of respiratory syncytial virus (RSV) disease and RSV vaccine eligibility is low among hospitalized older adults, ...

Australians are preparing for significant numbers of respiratory infections this winter, as cases of influenza, RSV, and ...

COVID, flu and RSV levels have already hit their peaks. (Pollen levels and springtime allergies are a whole different story.) ...

The European Commission approved Pfizer's respiratory syncytial virus vaccine for the prevention of lower respiratory tract ...

The Ministry of Public Health (MoPH) has advised the public, especially the vulnerable to take the Respiratory Syncytial ...

Coronavirus and respiratory syncytial virus (RSV) are two kinds of respiratory viruses that can infect you and have similar symptoms. It can be hard to tell the difference between infections ...